Because of its appetite-suppressing effect, many patients do well sticking to a two-to-three meal a day plan
Appetite suppression remains the primary ongoing effect, which is the desired therapeutic outcome
By focusing on these three receptors, the medication reduces appetite and slows digestion, leading to weight loss
Retatrutide dosage chart for weight loss: A comprehensive guide Looking for the ultimate weight loss medication
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog